Max Healthcare Institute Limited has informed the Exchange about change in Senior Management Personnel

Kmp ResignedManagement Changes View source PDF Explain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.2%Reaction day

₹1223.00

prior close

₹1229.80

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.2%-3.0% vs market

Hospital peers, median of 20sector-0.2%-3.0% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty 100 and 3.0 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-0.7

15m

-1.1

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.2-0.2-3.0-0.2-3.0

Next day

-5.2-0.5-4.7-2.1-3.1

-1.4+0.8-2.2-1.0-0.4

-2.7+0.3-3.1-1.7-1.0

-1.9+0.7-2.6-1.1-0.8

+1.3+1.5-0.2-0.2+1.4

+4.3+3.1+1.2+1.5+2.7

15d

+1.9+2.5-0.6+6.1-4.3

-0.6+0.7-1.3+5.9-6.5

-0.4+0.2-0.6+10.5-10.9

-4.1+2.5-6.6+12.3-16.4

UpDownMarket · Nifty 100Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Varadhan Moorthy, Director - Projects at Max Healthcare, has resigned from the company effective closing hours on June 16, 2025. The resignation was submitted on March 18, 2025 and accepted on June 16, 2025 after serving a 90-day notice period. The reason cited is personal reasons, specifically relocation to his hometown. Mr. Moorthy had been associated with the company since September 14, 2023. The company has confirmed the cessation and disclosed this under SEBI LODR Regulation 30.

Likely market impact

This is a routine mid-to-senior level exit driven by personal relocation, not a top C-suite departure. No immediate operational or governance red flags are evident, and minimal impact on shareholders or stock price is expected. Investors may want to track who fills the Director - Projects role.